Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
IGC Pharma
AddedFeb 19, 2024
UpdatedJul 4, 2026
IGC Pharma

IGC Pharma

Public

IGC Pharma: A US-based biopharmaceutical firm developing cannabinoid therapies for various conditions.

HQ
Potomac, MD, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to develop innovative cannabinoid-based therapies, IGC Pharma, Inc. focuses on addressing significant medical conditions such as Alzheimer's disease, period cramps, premenstrual syndrome (PMS), and chronic pain. The company aims to revolutionize the healthcare sector in the United States by offering novel treatments that leverage the therapeutic potential of cannabinoids. One of their key products, IGC-AD1, is currently in Phase 2b trials for treating agitation in dementia due to Alzheimer's disease, showcasing their commitment to tackling complex neurological disorders.

IGC Pharma has garnered attention through its research and development efforts, particularly in the field of Alzheimer's disease. The company's leadership includes experienced professionals in biopharmaceuticals and cannabinoid research, contributing to its growing reputation in the industry. Notable investors and partnerships have supported its innovative approach, enabling significant advancements in clinical trials. Overall, IGC Pharma's impact lies in its potential to provide effective cannabinoid-based treatments, offering hope to millions affected by chronic and debilitating conditions.

IGC Pharma - Similar Companies

IGC BIO logo

IGC BIO

Icvrx logo

Icvrx

Ikaria logo

Ikaria

Pure Green Pharmaceuticals logo

Pure Green Pharmaceuticals

pgpharma.co

Igenica logo

Igenica

Emerald Health Pharmaceuticals logo

Emerald Health Pharmaceuticals

IGM Biosciences logo

IGM Biosciences

igmbio.com

iQure Pharma logo

iQure Pharma

iqurepharma.com

Adtech Pharma logo

Adtech Pharma

adtechpharma.com

Tioga Pharmaceuticals logo

Tioga Pharmaceuticals

Intra-Cellular Therapies logo

Intra-Cellular Therapies

PIN Pharma logo

PIN Pharma

pinpharma.com

Anthera Pharmaceuticals logo

Anthera Pharmaceuticals

anthera.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

IGC Pharma - Quick Facts

Who are IGC Pharma's competitors?

Companies similar to IGC Pharma include IGC BIO, Icvrx, Ikaria and Pure Green Pharmaceuticals.

When was IGC Pharma founded?

IGC Pharma was founded in 2005.

Where is IGC Pharma's headquarters located?

IGC Pharma's headquarters is located in Potomac, MD, US.

When was IGC Pharma's last funding round?

IGC Pharma's most recent funding round was for $12M (USD) in July 2023.

How much has IGC Pharma raised to-date?

As of Jul 7, 2023, IGC Pharma has raised a total of $15.3M (USD).

How many employees does IGC Pharma have?

IGC Pharma has 50 employees as of Feb 6, 2024.

IGC Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • secCik: 0001326205
  • ticker: IGC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 32 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 423000Merchant Wholesalers, Durable Goods
  • 423600Household Appliances and Electrical and Electronic Goods Merchant Wholesalers
  • 423690Other Electronic Parts and Equipment Merchant Wholesalers
  • 425000Wholesale Trade Agents and Brokers
  • 425120Wholesale Trade Agents and Brokers
  • 440000Retail Trade
  • 449000Furniture, Home Furnishings, Electronics, and Appliance Retailers
  • 449200Electronics and Appliance Retailers
  • 449210Electronics and Appliance Retailers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 425100Wholesale Trade Agents and Brokers
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 1000Metal Mining
  • 1600Heavy Construction Other Than Building Construction-contractors
  • 2000Food And Kindred Products
  • 3000Rubber And Miscellaneous Plastics Products
  • 5060Electrical Goods
  • 5065Electronic Parts and Equipment, Not Elsewhere Classified
  • 5000Wholesale Trade-durable Goods
  • 6700Holding And Other Investment Offices
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research